157 related articles for article (PubMed ID: 31851643)
1. Serum Uric Acid Shows Inverted "U" Type Correlation with Osteoporosis in Chinese Ankylosing Spondylitis Patients: A Retrospective Study.
Chen Z; Yang P; Wu Y; Liu X; Yang Y; Song P; Chen YT; Lin C; Xu Q
Med Sci Monit; 2019 Dec; 25():9702-9711. PubMed ID: 31851643
[TBL] [Abstract][Full Text] [Related]
2. The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis.
Mermerci Başkan B; Pekin Doğan Y; Sivas F; Bodur H; Ozoran K
Rheumatol Int; 2010 Jan; 30(3):375-81. PubMed ID: 19685057
[TBL] [Abstract][Full Text] [Related]
3. Relationship of bone mineral density with disease activity and functional ability in patients with ankylosing spondylitis: a cross-sectional study.
Grazio S; Kusić Z; Cvijetić S; Grubišić F; Balenović A; Nemčić T; Matijević-Mikelić V; Punda M; Sieper J
Rheumatol Int; 2012 Sep; 32(9):2801-8. PubMed ID: 21858541
[TBL] [Abstract][Full Text] [Related]
4. Low levels of serum uric Acid increase the risk of low bone mineral density in young male patients with ankylosing spondylitis.
Kang KY; Hong YS; Park SH; Ju JH
J Rheumatol; 2015 Jun; 42(6):968-74. PubMed ID: 25834199
[TBL] [Abstract][Full Text] [Related]
5. The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis.
Arends S; Spoorenberg A; Bruyn GA; Houtman PM; Leijsma MK; Kallenberg CG; Brouwer E; van der Veer E
Osteoporos Int; 2011 May; 22(5):1431-9. PubMed ID: 20603707
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of osteoporosis and vertebral fractures and related factors in patients with ankylosing spondylitis.
Ulu MA; Batmaz İ; Dilek B; Çevik R
Chin Med J (Engl); 2014; 127(15):2740-7. PubMed ID: 25146606
[TBL] [Abstract][Full Text] [Related]
7. Elevated serum levels of soluble receptor activator of nuclear factors-kappaB ligand (sRANKL) and reduced bone mineral density in patients with ankylosing spondylitis (AS).
Kim HR; Lee SH; Kim HY
Rheumatology (Oxford); 2006 Oct; 45(10):1197-200. PubMed ID: 16567356
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and risk factors of osteoporosis in patients with ankylosing spondylitis: a 5-year follow-up study of 504 cases.
Wang DM; Zeng QY; Chen SB; Gong Y; Hou ZD; Xiao ZY
Clin Exp Rheumatol; 2015; 33(4):465-70. PubMed ID: 25962324
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral density, bone metabolism-related factors, and microRNA-218 are correlated with disease activities in Chinese ankylosing spondylitis patients.
Liu J; Zhao L; Yang X; Liu C; Kong N; Yu Y; Xuan D; Wan W; Xue Y
J Clin Lab Anal; 2022 Feb; 36(2):e24223. PubMed ID: 34984723
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers of bone metabolism in ankylosing spondylitis in relation to osteoproliferation and osteoporosis.
Klingberg E; Nurkkala M; Carlsten H; Forsblad-d'Elia H
J Rheumatol; 2014 Jul; 41(7):1349-56. PubMed ID: 24931960
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor is a potential biomarker for osteoproliferation and osteoporosis in ankylosing spondylitis.
Torres L; Klingberg E; Nurkkala M; Carlsten H; Forsblad-d'Elia H
Osteoporos Int; 2019 Feb; 30(2):441-449. PubMed ID: 30306221
[TBL] [Abstract][Full Text] [Related]
12. Severity of Sacroiliitis and Erythrocyte Sedimentation Rate are Associated with a Low Trabecular Bone Score in Young Male Patients with Ankylosing Spondylitis.
Kang KY; Chung MK; Kim HN; Hong YS; Ju JH; Park SH
J Rheumatol; 2018 Mar; 45(3):349-356. PubMed ID: 29335346
[TBL] [Abstract][Full Text] [Related]
13. Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?
Saad CG; Ribeiro AC; Moraes JC; Takayama L; Goncalves CR; Rodrigues MB; de Oliveira RM; Silva CA; Bonfa E; Pereira RM
Arthritis Res Ther; 2012 Oct; 14(5):R216. PubMed ID: 23062122
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and risk factors of low bone mineral density in juvenile onset ankylosing spondylitis.
Bao J; Chen Y; Bao YX
Calcif Tissue Int; 2014 Aug; 95(2):108-11. PubMed ID: 24854154
[TBL] [Abstract][Full Text] [Related]
15. Changes in bone density in patients with ankylosing spondylitis: a two-year follow-up study.
Maillefert JF; Aho LS; El Maghraoui A; Dougados M; Roux C
Osteoporos Int; 2001; 12(7):605-9. PubMed ID: 11527060
[TBL] [Abstract][Full Text] [Related]
16. [The value of researches, which assess bone mineral density and bone metabolism in patients with ankylosing spondylitis, in detecting osteoporosis].
Przepiera-Bedzak H
Ann Acad Med Stetin; 2007; 53(3):39-47. PubMed ID: 18595484
[TBL] [Abstract][Full Text] [Related]
17. The change of bone mineral density according to treatment agents in patients with ankylosing spondylitis.
Kang KY; Lee KY; Kwok SK; Ju JH; Park KS; Hong YS; Kim HY; Park SH
Joint Bone Spine; 2011 Mar; 78(2):188-93. PubMed ID: 20621536
[TBL] [Abstract][Full Text] [Related]
18. Which measuring site in ankylosing spondylitis is best to detect bone loss and what predicts the decline: results from a 5-year prospective study.
Deminger A; Klingberg E; Lorentzon M; Geijer M; Göthlin J; Hedberg M; Rehnberg E; Carlsten H; Jacobsson LT; Forsblad-d'Elia H
Arthritis Res Ther; 2017 Dec; 19(1):273. PubMed ID: 29216909
[TBL] [Abstract][Full Text] [Related]
19. Factors relating to bone mineral density in young and middle-aged patients with ankylosing spondylitis.
Wu X; Zhong JY; Wang G; Xu HJ
Chin Med J (Engl); 2021 Oct; 134(21):2556-2563. PubMed ID: 34653076
[TBL] [Abstract][Full Text] [Related]
20. The urinary β
Zhou X; Hong W; Chen W; Feng X; Zhang Z; Zhang X; Fu C; Xiao J; Ye Z
Arch Osteoporos; 2020 Jun; 15(1):90. PubMed ID: 32556596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
